You need to enable JavaScript to run this app.
Recon: FDA adcomm recommends Eisai-Biogen Leqembi; Novartis inks deal to buy Chinook for $3.5B
Recon
Joanne S. Eglovitch
Global
ReconJoanne S. Eglovitch
GlobalReconJoanne S. EglovitchGlobal